Streetbeat News

Stock Prices

BGNE

NVS

BeiGene Ltd has announced it will regain rights to develop, manufacture, and commercialize its cancer drug, Tevimbra, from Novartis AG. The European Commission has approved Tevimbra as a monotherapy for adults with certain types of cancer, and the FDA has accepted the biologics license application for the drug, with a target action date in the second half of 2024. BeiGene's shares are up 0.14% premarket.

Portfolio Pulse from Vandana Singh

September 19, 2023 | 1:18 pm

SHFS

Safe Harbor Financial (NASDAQ:SHFS) is launching a new portfolio of line of credit products for cannabis businesses. The credit facilities will range from $25,000 to $1 million at market-leading rates. This follows Safe Harbor's launch of interest-bearing commercial accounts in July. The company's shares were trading 5.27% higher at $0.82 per share during Monday’s pre-market session.

Portfolio Pulse from Nina Zdinjak

September 19, 2023 | 1:18 pm

ACB

Aurora Cannabis Inc. (NASDAQ:ACB) has received approval to transfer its common shares listing from the Nasdaq Global Select Market to the Nasdaq Capital Market. This move is expected to allow the company an additional 180 days to regain compliance with the Nasdaq Listing Rule 5450(a)(1). Aurora also announced that it has agreed to repurchase an aggregate of roughly CA$13 million ($9.6 million) principal amount of its convertible senior notes. This is part of the company's strategy to reduce its debt and boost financial stability.

Portfolio Pulse from Jelena Martinovic

September 19, 2023 | 1:16 pm

RXT

Raymond James has upgraded Rackspace Technology's stock from Market Perform to Outperform and set a price target of $3.5. This has led to an increase in the trading of Rackspace Technology shares.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:14 pm

DATS

Trading of DatChat shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:14 pm

AMAT

Applied Materials, Inc. (AMAT) shares have dropped by about 4% amid recent volatility in semiconductor and chip stocks. This is due to Taiwan Semiconductor Manufacturing Company (TSMC) reportedly telling its suppliers to postpone the delivery of high-end chipmaking equipment due to demand uncertainty. As a major supplier of such equipment, Applied Materials' revenue and earnings could be directly affected if TSMC delays or postpones orders.

Portfolio Pulse from Henry Khederian

September 19, 2023 | 1:10 pm

NKLA

Nikola Corp (NASDAQ:NKLA) shares are trading lower after a surge on Monday following the announcement of a new chief operating officer, Mary Chan. Chan, who previously served as a managing partner at VectoIQ and as president and COO of VectoIQ Acquisition Corp, will lead several teams at Nikola, including engineering, program, product, supply chain, and manufacturing. Nikola's CEO, Steve Girsky, believes Chan's appointment will streamline decision-making processes and improve the company's engineering and manufacturing capabilities.

Portfolio Pulse from Adam Eckert

September 19, 2023 | 1:08 pm

DAVA

Endava reported its Q4 financial results and issued guidance, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:07 pm

CNXA

CTNT

EBET

ELYS

FFIE

FRSX

JZXN

NIO

SSU

TRNR

UFAB

WKSP

During Tuesday's pre-market session, several consumer discretionary stocks experienced significant movement. Gainers included Connexa Sports Techs (CNXA), Unique Fabricating (UFAB), Interactive Strength (TRNR), Elys Game Technology (ELYS), Foresight Autonomous (FRSX), and Worksport (WKSP). Losers included Faraday Future (FFIE), SIGNA Sports United (SSU), NIO (NIO), Jiuzi Hldgs (JZXN), EBET (EBET), and Cheetah Net Supply Chain (CTNT).

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 1:06 pm

LGVNR

UPH

During Tuesday's pre-market session, several healthcare stocks experienced significant movements. Longeveron Inc., Avinger, Navidea Biopharmaceutical, Elutia, ABVC BioPharma, and Akili saw increases in their shares, with Longeveron Inc. leading with a 172.7% increase. On the other hand, UpHealth, 60 Degrees, T2 Biosystems, SCWorx, Kinnate Biopharma, and MSP Recovery saw decreases in their shares, with UpHealth experiencing the largest decline of 50%.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 1:06 pm